Pharmacy Times

JULY 8, 2022

Findings suggest that the HER2 L755S mutation plays a role in the aggressiveness of lobular breast cancer observed in the clinic.

139

139

pharmaphorum

JULY 8, 2022

The pharmaceutical industry is increasingly relying on artificial intelligence to power its drug discovery and development efforts, and its spend in this area has created a multibillion-dollar market for AI technologies. That’s the conclusion of a GlobalData report , which notes that AI is being used to enhance computer-aided drug design (CADD) in a bid to reduce the time and costs involved in getting a new drug to market.

Compounding 131

Compounding 131

Pharmacy Times

JULY 8, 2022

David Pope, PharmD, CDE, the EVP of Innovation and Industry Relations at OmniSYS, discusses the FDA’s announcement updating pharmacists’ prescriptive authority for the COVID-19 antiviral Paxlovid.

FDA 132

FDA 132

European Pharmaceutical Review

JULY 8, 2022

As established facilities age, various risk considerations emerge. While some may continue to function effectively without any additional considerations, many will require additional checks and assessment. In an article published in the Journal of Validation Technology (JVT), pharmaceutical microbiologist and contamination control expert Tim Sandle identified ten categories of risk presented by aging.

128

128

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

JULY 8, 2022

Simple changes to each day can improve motivation and wellness for pharmacists.

131

131

pharmaphorum

JULY 8, 2022

The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinical trial space. Hybrid or decentralised clinical trials (DCTs) have gained traction as technology, infrastructure and knowledge have evolved to support their use. Preliminary research suggests that hybrid DCTs can reduce trial timing and resources , improve patient-centricity and patient engagement , and expand access and recruitment and increase diversity , mitigate bias, and re

FDA 100

FDA 100

Pharmaceutical Commerce

JULY 8, 2022

How did the industry get here and what alternatives can be sought out?

98

98

Pharmacy Times

JULY 8, 2022

Hypervitaminosis D, a condition characterized by elevated vitamin D levels, is associated with potential serious health issues, such as psychosis, abdominal pain, vomiting, pancreatitis, and renal failure.

123

123

PharmExec

JULY 8, 2022

Continent has shed its ‘emerging’ status on world biopharma stage.

98

98

Pharmacy Times

JULY 8, 2022

ProAir Digihaler Inhalation Powder is indicated for the treatment or prevention of bronchospasm in those with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.

123

123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

PharmExec

JULY 8, 2022

Dealing with discrimination and bias throughout her career, Otsuka Pharmaceutical’s Christine Sakdalan has forged a strong leadership path built around a two-pronged mission—finding true meaning in the patient journey through market research and data analytics, and mentoring and supporting the development of today’s aspiring professionals.

72

72

Pharmacy Times

JULY 8, 2022

In February of this year, the new statistics came out where we're at now 37 million with diabetes and 96 million with prediabetes.

73

73

PharmExec

JULY 8, 2022

COVID-19 pandemic, the challenging capital-markets climate in biotech, and a more innovative and specialty treatment focus has increased reliance on the finance arm as a key strategic cog.

69

69

Pharmacy Times

JULY 8, 2022

The Pharmacist Patient Care Process provides really consistent language for pharmacists and pharmacy team members to talk about what teams are already doing.

Patient Care 65

Patient Care 65

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmaceutical Technology

JULY 8, 2022

Swedish Orphan Biovitrum AB (Sobi) has signed an exclusive licence agreement with ADC Therapeutics to develop and market Zynlonta (loncastuximab tesirine) for hematologic and solid tumour indications in Europe and mostinternational markets, for up to $435m. The deal, however, excludes the US, Greater China, Singapore and Japan. Zynlonta is a CD19-directed antibody-drug conjugate (ADC).

64

64

Pharmacy Times

JULY 8, 2022

Christine Walko, PharmD, BCOP, FCCP, discusses some new developments for PARP inhibitors in cancer care for patients with homologous recombination deficiency.

65

65

PharmExec

JULY 8, 2022

Issue represents a potential threat in fighting future pandemics.

59

59

Pharmacy Times

JULY 8, 2022

By using technology solutions, pharmacists can be further integrated into the care team.

65

65

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmaceutical Technology

JULY 8, 2022

Over recent years, bispecific T-cell engagers (BiTEs) have attracted significant attention for their potential in treating a plethora of haematological and solid tumours by enhancing the anti-tumour responses of endogenous T-cells. BiTEs are a relatively nascent modality and have yet to benefit from the identification of robust biomarkers and novel combination approaches, such as in combination with anti-CD20 therapies, with the view to attenuate malignant B-cell survival and enhance clinical re

Chemotherapy 59

Chemotherapy Immunization FDA 59

Pharmacy Times

JULY 8, 2022

BurnAid burn dressing provides relief for all types of minor burns.

65

65

Pharmaceutical Technology

JULY 8, 2022

Europe was the fastest growing region for cloud hiring among pharmaceutical industry companies in the three months ending April. The number of roles in Europe made up 16.2% of total cloud jobs - up from 13.6% in the same quarter last year. That was followed by North America, which saw a 0.3 year-on-year percentage point change in cloud roles. The figures are compiled by GlobalData, who track the number of new job postings from key companies in various sectors over time.

59

59

Pharmacy Times

JULY 8, 2022

Tildrakizumab-asmn (Ilumya) is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

65

65

Pharmaceutical Technology

JULY 8, 2022

Digitalization related jobs that were closed during Q1 2022 had been online for an average of 34 days when they were taken offline. This was an increase compared to the equivalent figure a year earlier, indicating that the required skillset for these roles has become harder to find in the past year. Digitalization is one of the topics that GlobalData, our parent company and from whom the data for this article is taken, have identified as being a key disruptive technology force facing companies i

59

59

Pharmacy Times

JULY 8, 2022

Christopher Fine, MD, FACC, a cardiologist at National Jewish Health, discusses the relationship between heart disease and cancer and the importance of the field of cardio-oncology when treating patients with cancer.

65

65

Pharmaceutical Technology

JULY 8, 2022

Xenetic Biosciences and Catalent Pharma Solutions have signed an agreement for the cGMP manufacturing of the Xenetic’s recombinant protein, Human DNase I. Under the deal, Catalent will use its biomanufacturing capabilities in Madison, Wisconsin to advance Xenetic’s DNase clinical development programme and progress it to first-in-human studies. The interventional DNase based oncology platform of Xenetic is intended to boost outcomes of current therapies, including immunotherapies.

Chemotherapy 59

Chemotherapy Immunization 59

Pharma Times

JULY 8, 2022

The therapy will be used for specific muscle invasive urothelial cancer patients

52

52

Board Vitals - Pharmacist

JULY 8, 2022

Failure is a part of life, even in healthcare. While mistakes will inevitably happen, we must learn from these errors in order to have a greater chance of success in the future. As part of a commitment to supporting the doctors of the future, BoardVitals awarded its third annual Medical School Scholarship to three winners. For the 2022 BoardVitals Medical School Scholarship , we asked current medical students to answer the question: “What have you learned from previous failures and how have thes

Medical Schools 52

Medical Schools Communication 52

PharmD Live

JULY 8, 2022

Burnout can keep the best from wanting to open the doctor’s office each day. A national survey, The Physician Task Load and the Risk of Burnout Among US Physicians ( The Joint Commission Journal on Quality and Patient Safety 2021; 47:76–85 ), describes the look and feel of an albatross around the necks of struggling providers. The metaphor is supported by the direct relationship between physician task load and burnout.

Medical Records 52

Medical Records Patient Care 52

NICE

JULY 8, 2022

The course is made up of six learning modules and can be found on the EHDEN Academy website. The EHDEN Academy is a free learning resource, focusing on providing the knowledge, skills, and tools to access and use real-world evidence. Innovative medical technologies and devices are increasingly important in delivering positive health outcomes and driving health efficiencies.

52

52

The Luxe Pharmacist

JULY 8, 2022

I am a huge sucker for a sale, especially when it’s at one of my favorite stores! I mean why buy boots two months from now when you can buy them this week for like $70 less right?! I’m linking all my favorite sales pics here and will be uploading more on my LTK so be sure to follow me there!

52

52

PharmExec

JULY 8, 2022

Pharm Exec introduces new members to EAB.

52

52

Pharmaceutical Technology

JULY 8, 2022

Hardware and software systems are increasing in speed and sophistication while reducing in cost, making the infrastructure that virtual data rooms (VDR) provide more attractive as secure platforms for secure sharing and collaboration on confidential information. In addition, there are many innovative, layered, functionalities that reinforce the value of a VDR.

Documentation 52

Documentation 52

PharmExec

JULY 8, 2022

Legislative-reform alliance makes for strange bedfellows.

52

52